Company / Gross Margin
ACCENDRA HEALTH INC/VA/ Gross Margin History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
82.8%
FY2024
5-year range
12.3% / 83.3%
FY2020-FY2024
Trend
-0.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has fluctuated over the past 9 years, ranging from 11.4% in FY2019 to 83.3% in FY2023.
Based on SEC 10-K filings.
82.8% in FY2024 with a 5-year CAGR of +71.4%.
Improved from 18.4% to 82.8% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +70.5pp
- 5-Year Change
- +71.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, gross margin decreased 0.6% year-over-year.
- Peak gross margin was recorded in FY2023.
- Lowest gross margin in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | 82.8% | -0.6% |
| FY2023 | 83.3% | +353.7% |
| FY2022 | 18.4% | +49.8% |
| FY2021 | 12.3% | -18.9% |
| FY2020 | 15.1% | +32.8% |
| FY2019 | 11.4% | +0.0% |
| FY2018 | 11.4% | -9.6% |
| FY2017 | 12.6% | +3.0% |
| FY2016 | 12.2% | -1.8% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026